Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Diffusion Pharmaceuticals...

    NASDAQ: DFFN · Real-Time Price · USD
    4.40
    0.41 (10.28%)
    At close: Aug 16, 2023, 8:00 PM

    Diffusion Pharmaceuticals Statistics

    Share Statistics

    Diffusion Pharmaceuticals has 2.04M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 2.04M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 1,506

    FTD / Avg. Volume

    n/a
    		 3.15%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -1.02 and the forward PE ratio is null. Diffusion Pharmaceuticals's PEG ratio is 0.02.

    PE Ratio

    n/a
    		 -1.02

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 0.77

    P/FCF Ratio

    n/a
    		 -1.03

    PEG Ratio

    n/a
    		 0.02
    Financial Ratio History

    Enterprise Valuation

    Diffusion Pharmaceuticals has an Enterprise Value (EV) of 5.35M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 -0.34

    EV / EBIT

    n/a
    		 -0.36

    EV / FCF

    n/a
    		 -0.36

    Financial Position

    The company has a current ratio of 9.36, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 9.36

    Quick Ratio

    n/a
    		 9.36

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 41.95

    Financial Efficiency

    Return on Equity is -75.23% and Return on Invested Capital is -77.07%.

    Return on Equity

    n/a
    		 -75.23%

    Return on Assets

    n/a
    		 -67.2%

    Return on Invested Capital

    n/a
    		 -77.07%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,170,052

    Employee Count

    n/a
    		 13

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -380.75K

    Effective Tax Rate

    n/a
    		 2.44%

    Stock Price Statistics

    The stock price has increased by -33.33% in the last 52 weeks. The beta is 1.76, so Diffusion Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.76

    52-Week Price Change

    n/a
    		 -33.33%

    50-Day Moving Average

    n/a
    		 4.99

    200-Day Moving Average

    n/a
    		 7.18

    Relative Strength Index (RSI)

    n/a
    		 78.62

    Average Volume (20 Days)

    n/a
    		 47,812

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -15.97M

    Net Income

    n/a
    		 -15.21M

    EBITDA

    n/a
    		 -15.97M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -7.46
    Full Income Statement

    Balance Sheet

    The company has 10.11M in cash and 0 in debt, giving a net cash position of 10.11M.

    Cash & Cash Equivalents

    n/a
    		 10.11M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -145.6M

    Total Assets

    n/a
    		 12.04M

    Working Capital

    n/a
    		 10.76M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -14.97M and capital expenditures 0, giving a free cash flow of -14.97M.

    Operating Cash Flow

    n/a
    		 -14.97M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -14.97M

    FCF Per Share

    n/a
    		 -7.34
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    DFFN does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -98.34%

    FCF Yield

    n/a
    		 -96.78%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for DFFN.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Aug 17, 2023. It was a backward split with a ratio of 2:3.

    Last Split Date

    n/a
    		 Aug 17, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 2:3

    Scores

    Altman Z-Score

    n/a
    		 1786.86

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist